StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a report released on Thursday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP opened at $1.08 on Thursday. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.28 and a quick ratio of 6.41. Retractable Technologies has a one year low of $0.95 and a one year high of $1.85. The firm has a market capitalization of $32.19 million, a P/E ratio of -4.48 and a beta of 2.11. The business has a fifty day moving average of $1.18 and a 200 day moving average of $1.16.

Institutional Trading of Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. WealthTrust Axiom LLC raised its stake in shares of Retractable Technologies, Inc. (NYSE:RVP) by 27.8% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 126,533 shares of the company’s stock after purchasing an additional 27,500 shares during the period. WealthTrust Axiom LLC owned 0.42% of Retractable Technologies worth $151,000 as of its most recent SEC filing. Institutional investors and hedge funds own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.